Waters ROE 2010-2024 | WAT
Current and historical return on equity (ROE) values for Waters (WAT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Waters ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-09-30 | $0.62B | $1.60B | 45.96% |
| 2024-06-30 | $0.60B | $1.41B | 50.46% |
| 2024-03-31 | $0.60B | $1.26B | 59.16% |
| 2023-12-31 | $0.64B | $1.15B | 75.05% |
| 2023-09-30 | $0.65B | $0.91B | 94.07% |
| 2023-06-30 | $0.68B | $0.77B | 119.47% |
| 2023-03-31 | $0.69B | $0.60B | 146.52% |
| 2022-12-31 | $0.71B | $0.50B | 171.01% |
| 2022-09-30 | $0.70B | $0.39B | 183.42% |
| 2022-06-30 | $0.70B | $0.39B | 196.36% |
| 2022-03-31 | $0.70B | $0.38B | 215.62% |
| 2021-12-31 | $0.69B | $0.37B | 238.21% |
| 2021-09-30 | $0.69B | $0.30B | 270.57% |
| 2021-06-30 | $0.66B | $0.27B | 383.16% |
| 2021-03-31 | $0.62B | $0.23B | 1075.98% |
| 2020-12-31 | $0.52B | $0.23B | -614.12% |
| 2020-09-30 | $0.51B | $-0.04B | -256.35% |
| 2020-06-30 | $0.52B | $-0.19B | -327.62% |
| 2020-03-31 | $0.54B | $-0.34B | 1820.34% |
| 2019-12-31 | $0.59B | $-0.22B | 166.29% |
| 2019-09-30 | $0.58B | $0.12B | 71.84% |
| 2019-06-30 | $0.58B | $0.56B | 46.63% |
| 2019-03-31 | $0.59B | $0.97B | 37.02% |
| 2018-12-31 | $0.59B | $1.57B | 31.54% |
| 2018-09-30 | $0.06B | $1.88B | 2.73% |
| 2018-06-30 | $0.05B | $1.98B | 2.28% |
| 2018-03-31 | $0.03B | $2.12B | 1.14% |
| 2017-12-31 | $0.02B | $2.23B | 0.86% |
| 2017-09-30 | $0.55B | $2.63B | 22.27% |
| 2017-06-30 | $0.54B | $2.52B | 22.67% |
| 2017-03-31 | $0.53B | $2.40B | 23.42% |
| 2016-12-31 | $0.52B | $2.30B | 23.65% |
| 2016-09-30 | $0.50B | $2.26B | 23.25% |
| 2016-06-30 | $0.49B | $2.15B | 23.63% |
| 2016-03-31 | $0.47B | $2.10B | 23.17% |
| 2015-12-31 | $0.47B | $2.06B | 23.98% |
| 2015-09-30 | $0.47B | $1.97B | 24.49% |
| 2015-06-30 | $0.47B | $1.93B | 24.75% |
| 2015-03-31 | $0.46B | $1.86B | 24.56% |
| 2014-12-31 | $0.43B | $1.90B | 23.30% |
| 2014-09-30 | $0.42B | $1.84B | 23.23% |
| 2014-06-30 | $0.41B | $1.84B | 23.11% |
| 2014-03-31 | $0.40B | $1.82B | 23.75% |
| 2013-12-31 | $0.45B | $1.76B | 28.22% |
| 2013-09-30 | $0.48B | $1.62B | 31.83% |
| 2013-06-30 | $0.49B | $1.52B | 33.48% |
| 2013-03-31 | $0.49B | $1.48B | 35.69% |
| 2012-12-31 | $0.46B | $1.47B | 34.55% |
| 2012-09-30 | $0.42B | $1.33B | 33.12% |
| 2012-06-30 | $0.43B | $1.26B | 34.43% |
| 2012-03-31 | $0.43B | $1.29B | 34.86% |
| 2011-12-31 | $0.43B | $1.23B | 36.28% |
| 2011-09-30 | $0.42B | $1.16B | 36.66% |
| 2011-06-30 | $0.42B | $1.23B | 38.09% |
| 2011-03-31 | $0.40B | $1.15B | 40.55% |
| 2010-12-31 | $0.38B | $1.07B | 42.34% |
| 2010-09-30 | $0.36B | $0.92B | 42.38% |
| 2010-06-30 | $0.34B | $0.81B | 41.89% |
| 2010-03-31 | $0.33B | $0.81B | 41.08% |
| 2009-12-31 | $0.32B | $0.85B | 42.68% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $22.584B | $2.956B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $207.434B | 25.31 |
| Intuitive Surgical (ISRG) | United States | $194.997B | 101.95 |
| Edwards Lifesciences (EW) | United States | $43.303B | 27.50 |
| Alcon (ALC) | Switzerland | $41.141B | 27.53 |
| IQVIA Holdings (IQV) | United States | $36.894B | 20.33 |
| IDEXX Laboratories (IDXX) | United States | $34.232B | 40.31 |
| DexCom (DXCM) | United States | $30.373B | 45.74 |
| STERIS (STE) | Ireland | $20.308B | 23.38 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.662B | 0.00 |
| Hologic (HOLX) | United States | $16.272B | 17.57 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.198B | 13.55 |
| Globus Medical (GMED) | United States | $11.856B | 30.02 |
| Sysmex ADR (SSMXY) | Japan | $11.516B | 36.11 |
| Penumbra (PEN) | United States | $9.619B | 94.22 |
| Masimo (MASI) | United States | $8.910B | 43.11 |
| Glaukos (GKOS) | United States | $8.631B | 0.00 |
| Teleflex (TFX) | United States | $8.110B | 12.93 |
| Inari Medical (NARI) | United States | $4.642B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.532B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.486B | 25.42 |
| Veracyte (VCYT) | United States | $3.219B | 96.60 |
| LivaNova (LIVN) | United Kingdom | $2.534B | 14.63 |
| Nihon Kohden (NHNKY) | Japan | $2.370B | 18.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.364B | 0.00 |
| TransMedics (TMDX) | United States | $2.309B | 73.20 |
| Elekta AB (EKTAY) | Sweden | $2.138B | 19.22 |
| Integra LifeSciences Holdings (IART) | United States | $1.683B | 8.79 |
| Alphatec Holdings (ATEC) | United States | $1.414B | 0.00 |
| RxSight (RXST) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.253B | 83.00 |
| Pulse Biosciences (PLSE) | United States | $1.136B | 0.00 |
| OPKO Health (OPK) | United States | $1.003B | 0.00 |
| Paragon 28 (FNA) | United States | $0.867B | 0.00 |
| AxoGen (AXGN) | United States | $0.794B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.730B | 17.21 |
| IRadimed (IRMD) | United States | $0.717B | 38.76 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.699B | 11.88 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.650B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.592B | 0.00 |
| SiBone (SIBN) | United States | $0.575B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.575B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.498B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.476B | 25.05 |
| Treace Medical Concepts (TMCI) | United States | $0.455B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.413B | 22.38 |
| ClearPoint Neuro (CLPT) | United States | $0.405B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.367B | 0.00 |
| NeuroPace (NPCE) | United States | $0.356B | 0.00 |
| CVRx (CVRX) | United States | $0.344B | 0.00 |
| Inogen (INGN) | United States | $0.227B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.226B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.216B | 0.00 |
| Accuray (ARAY) | United States | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.165B | 0.00 |
| Nevro (NVRO) | United States | $0.123B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.114B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.111B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.107B | 11.47 |
| LENSAR (LNSR) | United States | $0.096B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| 908 Devices (MASS) | United States | $0.079B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.074B | 0.00 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| Hyperfine (HYPR) | United States | $0.069B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.061B | 31.57 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.057B | 0.00 |
| Neuronetics (STIM) | United States | $0.052B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.044B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.039B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.009B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |